Use of Dexamethasone, Remdesivir Against COVID-19 Varied Widely Across U.S. Health Systems
Johns Hopkins Bloomberg School of Public HealthAs many as one-fifth of patients hospitalized with severe COVID-19 in the United States who may have benefitted from treatment with the anti-inflammatory steroid dexamethasone or closely related drugs were not given such treatment at the height of the pandemic.